InvestorsHub Logo

12x

Followers 14
Posts 320
Boards Moderated 0
Alias Born 08/04/2022

12x

Re: Doc328 post# 409551

Sunday, 04/02/2023 10:29:43 AM

Sunday, April 02, 2023 10:29:43 AM

Post# of 461750
The $40k per AD patient in US trials (40M for 1,000 patients) seems lower than what SAVA spent but reasonable. SAVA reached 1,000 p3 AD patients in March 2023. The 2021 cash use was 30.2M, 77.5M used in 2022. Assuming the operation cash burn rate is similar between the years, 47M was used to recruit less than 1,000 patients.

https://www.cassavasciences.com/static-files/8c690141-7105-4740-a9f5-8652a40d4533
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News